• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Survival in influenza virus-related pneumonia by viral subtype: 2016-2020

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2021 Sep 18;S1201-9712(21)00743-8.
doi: 10.1016/j.ijid.2021.09.037. Online ahead of print.
Survival in influenza virus-related pneumonia by viral subtype: 2016-2020


Efrén Murillo-Zamora[SUP] 1 [/SUP], Xóchitl Trujillo[SUP] 2 [/SUP], Miguel Huerta[SUP] 3 [/SUP], Mónica Ríos-Silva[SUP] 4 [/SUP], José Guzmán-Esquivel[SUP] 5 [/SUP], Verónica Benites-Godínez[SUP] 6 [/SUP], Oliver Mendoza-Cano[SUP] 7 [/SUP]



Affiliations

Abstract

Background: Influenza remains a common cause of morbidity and mortality worldwide and viral subtype-related differences in disease outcomes have been documented.
Objective: To characterize the survival experience of adult inpatients with influenza virus-associated pneumonia by viral subtype during five consecutive flu seasons.
Method: We performed a retrospective cohort study and data from 4,678 adults were analyzed using the Kaplan-Meier method. A multivariate Cox proportional hazard regression model was fitted.
Results: The overall in-hospital mortality rate was 25.0 per 1,000 hospital-days. The survival probabilities from pneumonia patients went from 93.4% (95% CI 92.6-94.1%) by day 3 to 43.3% (95% CI 39.2-47.4%) in day 30 from hospital admission. In general, the lowest survival rates were observed in patients with AH1N1 infection. In multiple model, and after adjusting by comorbidities and when compared with A non-subtypified virus, pneumonia patients with AH3N2 or B strains had a significantly decreased risk of a non-favorable disease outcome. The association of other strains was not significant.
Conclusions: Our findings suggest that the survival of inpatients with influenza virus-associated pneumonia varies according to the pathogenic viral subtype and the lowest survival rates were observed in patients with AH1N1 infection. This effect was independent of the patients' gender, age, and the analyzed underlying health conditions.

Keywords: Influenza, Human; Inpatients; Pneumonia, Viral; Proportional Hazards Models; Survival Rate.
 
Back
Top Bottom